TAC regimen
Term · Oncology and biomedicine · MLC-T-ONC-008483
An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called TAC.
A regimen consisting of docetaxel, doxorubicin and cyclophosphamide that can be used in the treatment of breast cancer.
| Identifier | MLC-T-ONC-008483 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TAC; taxotere-Adriamycin-Cytoxan regimen; docetaxel/doxorubicin/cyclophosphamide; docetaxel/doxorubicin/cyclophosphamide regimen |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-008483",
"term": "TAC regimen",
"field": "Oncology and biomedicine",
"definitions": [
"An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called TAC.",
"A regimen consisting of docetaxel, doxorubicin and cyclophosphamide that can be used in the treatment of breast cancer."
],
"synonyms": [
"TAC",
"taxotere-Adriamycin-Cytoxan regimen",
"docetaxel/doxorubicin/cyclophosphamide",
"docetaxel/doxorubicin/cyclophosphamide regimen"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tac-regimen/"
}
Record 15,930 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.